Incyte
INCY
#978
Rank
NZ$43.61 B
Marketcap
NZ$213.96
Share price
1.39%
Change (1 day)
13.60%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2023 (TTM): NZ$3.12

According to Incyte's latest financial reports the company's current EPS (TTM) is NZ$3.76. In 2022 the company made an earnings per share (EPS) of NZ$2.75 a decrease over its 2021 EPS that were of NZ$7.67.

EPS history for Incyte from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$3.1213.14%
2022NZ$2.75-64.1%
2021NZ$7.67-408.63%
2020NZ-$2.49-166.83%
2019NZ$3.72300%
2018NZ$0.93-133.33%
2017NZ-$2.79-378.57%
2016NZ$1.002700%
2015NZ$0.03576-106.67%
2014NZ-$0.54-44.44%
2013NZ-$0.9750%
2012NZ-$0.64-75.68%
2011NZ-$2.65469.23%
2010NZ-$0.46-87.38%
2009NZ-$3.684.04%
2008NZ-$3.5492.23%
2007NZ-$1.8415.73%
2006NZ-$1.59-27.64%
2005NZ-$2.20-44.34%
2004NZ-$3.95-5.56%
2003NZ-$4.1815.27%
2002NZ-$3.63-26.71%
2001NZ-$4.95483.16%
2000NZ-$0.85-1.04%
1999NZ-$0.86-838.46%
1998NZ$0.12-59.38%
1997NZ$0.29-194.12%
1996NZ-$0.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.39 150.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.36-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$55.19 1,369.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$29.00 672.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$17.90 376.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ-$0.20-105.24%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ-$1.04-127.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
NZ-$1.50-140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ-$0.39-110.48%๐Ÿ‡บ๐Ÿ‡ธ USA